Friday, July 30, 2010

MDS sees revenue decline, but could be processing medical isotopes by April: CEO

January 23, 2010 by  
Filed under nuclear medicine

MDS sees revenue decline, but could be processing medical isotopes by April: CEO
TORONTO – The new CEO of nuclear medicine company MDS Inc. (TSX:MDS) says the company could be processing medical isotopes again as early as
Read more on Canadian Business

Powered by Yahoo! Answers